Commissioner Stephen Hahn says today’s meeting of the US Food and Drug Administration’s vaccine advisory panel to approve a shot developed by Pfizer is “an important day for all of America.”
The FDA head hopes it will lead to the beginning of the end of the pandemic and a return “to a more normal and healthy life.”
A nurse prepares the a dose of the Pfizer-BioNTech COVID-19 vaccine at the Northern General Hospital in Sheffield, Yorkshire on December 8, 2020. (Andy Stenning / POOL / AFP)
Hahn says the FDA is working to understand the allergic reactions that turned up when the United Kingdom began vaccinations this week and that FDA would include recommendations in any emergency use authorization as to who should and should not get the vaccine.
Hahn, addressing public skepticism of the vaccine, says if one authorized, it’s important for people to get vaccinated to arrive at herd immunity.
He says: “I have 100% confidence, and I think the American public should as well, with respect to our review of the safety and efficacy of the vaccine.”
He spoke this morning to ABC, CBS and NBC.
Israel is expected to follow suit should the FDA approve the Pfizer vaccine.
— with AP
We can't do this work alone.
The war with Iran has been draining for all of us in Israel. But when I heard about a high casualty incident – ballistic missile impacts in Arad and Dimona that left nearly 200 people wounded – I drank a cup of coffee, packed a bag, and headed south.
There, I spoke with Shilgit, the head of an after-school program for underprivileged youth. Standing outside her destroyed center, Shilgit said it was a miracle that no children were hurt and spoke about the community coming together in the hours since.
As a Times of Israel reporter, I’m committed to telling stories of resilience like Shilgit’s. But my colleagues and I can't do this alone. If you value work like this,please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to keep real human reporting like this going.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel